Aiste Lengvenyte1,2, Emilie Olié1,3, Philippe Courtet4,5. 1. Department of Psychiatric Emergency & Acute Care, Lapeyronie Hospital, CHU Montpellier, Montpellier, France. 2. Faculty of Medicine, Institute of Clinical Medicine, Psychiatric Clinic, Vilnius University, Vilnius, Lithuania. 3. Neuropsychiatry, Epidemiological and Clinical Research, INSERM, University of Montpellier, Montpellier, France. 4. Department of Psychiatric Emergency & Acute Care, Lapeyronie Hospital, CHU Montpellier, Montpellier, France. philippe.courtet@umontpellier.fr. 5. Neuropsychiatry, Epidemiological and Clinical Research, INSERM, University of Montpellier, Montpellier, France. philippe.courtet@umontpellier.fr.
Abstract
PURPOSE OF REVIEW: Suicidal behaviours are a challenge for a medical system and public health, partly due to the current lack of evidence-based, effective, rapid tools for suicidal crisis management. Ketamine and its enantiomer esketamine have raised hopes regarding this issue in the recent years. However, their efficacy in suicidal behaviours and mechanisms for it remain a topic of debate. RECENT FINDINGS: Subanesthetic ketamine doses rapidly, albeit transiently decrease suicidal ideation, with effects emerging within an hour and persisting up to a week. Current evidence points to various and not necessarily exclusive mechanisms for ketamine's antisuicidal action, including effects on neuroplasticity, inflammation, reward system and pain processing. Ketamine rapidly decreases suicidal ideation, but whether it leads to meaningful clinical outcomes past 1 week is unclear. Multiple putative mechanisms drive ketamine's antisuicidal action. Future studies will have to show long-term ketamine treatment outcomes and further elucidate its mechanisms of action.
PURPOSE OF REVIEW: Suicidal behaviours are a challenge for a medical system and public health, partly due to the current lack of evidence-based, effective, rapid tools for suicidal crisis management. Ketamine and its enantiomer esketamine have raised hopes regarding this issue in the recent years. However, their efficacy in suicidal behaviours and mechanisms for it remain a topic of debate. RECENT FINDINGS: Subanesthetic ketamine doses rapidly, albeit transiently decrease suicidal ideation, with effects emerging within an hour and persisting up to a week. Current evidence points to various and not necessarily exclusive mechanisms for ketamine's antisuicidal action, including effects on neuroplasticity, inflammation, reward system and pain processing. Ketamine rapidly decreases suicidal ideation, but whether it leads to meaningful clinical outcomes past 1 week is unclear. Multiple putative mechanisms drive ketamine's antisuicidal action. Future studies will have to show long-term ketamine treatment outcomes and further elucidate its mechanisms of action.
Authors: Anton Rogachov; Anuj Bhatia; Joshua C Cheng; Rachael L Bosma; Junseok A Kim; Natalie R Osborne; Kasey S Hemington; Lakshmikumar Venkatraghavan; Karen D Davis Journal: Pain Date: 2019-07 Impact factor: 6.961
Authors: Ying Xu; Maree Hackett; Gregory Carter; Colleen Loo; Verònica Gálvez; Nick Glozier; Paul Glue; Kyle Lapidus; Alexander McGirr; Andrew A Somogyi; Philip B Mitchell; Anthony Rodgers Journal: Int J Neuropsychopharmacol Date: 2016-04-20 Impact factor: 5.176
Authors: Mariam M Youssef; Mark D Underwood; Yung-Yu Huang; Shu-Chi Hsiung; Yan Liu; Norman R Simpson; Mihran J Bakalian; Gorazd B Rosoklija; Andrew J Dwork; Victoria Arango; J John Mann Journal: Int J Neuropsychopharmacol Date: 2018-06-01 Impact factor: 5.176
Authors: Aiste Lengvenyte; Robertas Strumila; Philippe Courtet; Scott Y H Kim; Emilie Olié Journal: Can J Psychiatry Date: 2020-06-05 Impact factor: 4.356
Authors: Juliana Surjan; Julia Diniz Grossi; José Alberto Del Porto; Rodrigo Simonini Delfino; Raphael de Oliveira Cerqueira; Ana Cecília Lucchese; Eduardo Magalhães; Lorena Catarina Del Sant; Marco Aurélio Tuena; Carolina Nakahira; Victor Augusto Rodovalho Fava; Matheus Souza Steglich; Guilherme Lozi Abdo; Matheus Ghossain Barbosa; Luciana Maria Sarin; Acioly Luiz Tavares Lacerda Journal: Clin Drug Investig Date: 2022-08-31 Impact factor: 3.580
Authors: Elise M Hawkins; William Coryell; Stephen Leung; Sagar V Parikh; Cody Weston; Paul Nestadt; John I Nurnberger; Adam Kaplin; Anupama Kumar; Ali A Farooqui; Rif S El-Mallakh Journal: Brain Behav Date: 2021-10-17 Impact factor: 2.708